Benzinga | Mar 15, 2021 07:17AM EDT

Ascendis Pharma To Participate At Oppenheimer 31st Annual Healthcare Conference Mar. 17 At 11:20 a.m. ET

COPENHAGEN, Denmark, March 15, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company that utilizes its innovative TransCon(tm) technologies to create product candidates that address unmet medical needs, today announced that the company will participate at the Oppenheimer 31st Annual Healthcare Conference. Company executives will provide a business overview and an update on the Company's pipeline programs.



Details

Event Oppenheimer 31st Annual Healthcare ConferenceLocation VirtualDate Wednesday, March 17, 2021Time 11:20 a.m. Eastern Time

A live webcast of the presentation will be available on the Investors and News section of the Company's website at www.ascendispharma.com. A webcast replay will also be available on the Company's website shortly after conclusion of the event for 30 days.